TABLE 4 Selected Summary of Uterine Non-Hodgkin's Lymphoma Reported in the Literature*
From: Non-Hodgkin's Lymphomas Involving the Uterus: A Clinicopathologic Analysis of 26 Cases
Study | Age (yr) | Sites (no.) | Presentation | Stages (no.) | Histologic type (no.) | Immunophenotype (no.) | Treatment (no.) | 5-yr survival rate (%) |
|---|---|---|---|---|---|---|---|---|
Harris and Scully (4) (n = 21) | 20–80 | Cervix (19), corpus (2) | AUB | IE (16) IIE (3) IV (2) | DLCL (12), FMCL (3), FLCL (3), FSCCL (1), Burkitt's (1), U (1) | B-cell (2) | Surgery (17), RT (12), CT (4) | 57 |
Stroh et al. (15) (n = 13) | 22–73 | Cervix (7), corpus (4), unknown (2) | AUB | IE (5) IIE (4) IIIE (1) IV (3) | DLCL (11), SLL (1), FSCCL (1) | ND (13) | CT (13), RT (9) | 70 |
Chorlton et al. (2) (n = 8) | 34–51 | Cervix (5), corpus (3) | Abdominal and pelvic mass | N/A | DLCL (3), U (3), SLL (1), DSCCL (1) | ND (8) | Surgery (5), RT (4), CT (3) | 33 |
Aosaza et al. (1) (n = 7) | 30–71 | Cervix (4), corpus (3) | AUB | IE (2) IIE (3) IIIE (1) N/A (1) | DLCL (5), DM (1), U (1) | B-cell (7) | RT (4), surgery (4), CT (3) | 0 |
Liang et al. (9) (n = 6) | 25–78 | Corpus + cervix (3), corpus (2), cervix (1) | N/A | IE (1) IV (5) | DLCL (4), LBL (1), DSNC (1) | B-cell (3), ND (3) | CT (6), RT (4) | 0 |
Muntz et al. (13) (n = 5) | 23–73 | Cervix (5) | AUB | IE (5) | DLCL (3), DSCCL (1), FSCCL (1) | B-cell (3) | RT (5), surgery (3) | 100 |
Monterroso et al. (12) (n = 5) | 22–77 | “Uterus” or corpus + cervix (3), corpus (2) | Abdominal and pelvic mass with ovarian NHL | IV (5) | DLCL (2), SNCB (2), follicular + diffuse LCL (1) | B-cell (5) | Surgery (5), CT (4) | N/A |
Delgado et al. (3) (n = 4) | 37–70 | Cervix (4) | AUB | N/A | DLCL (4) | ND (4) | RT (3), surgery (1) | N/A |
Iliya et al. (5) (n = 4) | 44–70 | Cervix (3), “uterus” (1) | AUB | IV (4) | DLCL (4) | ND (4) | RT (4), CT (3), surgery (1) | 0 |
Johnson et al. (6) (n = 4) | 40–67 | Corpus (2), corpus + cervix (1), cervix (1) | AUB | IV (4) | LBL (2), DLCL (1), SLL (1) | ND (4) | RT (4) | N/A |
Komaki et al. (7) (n = 3) | 38–43 | Cervix (3) | AUB | IIE (3) | DLCL (2), DM (1) | ND (3) | RT (3), CT (1) | 100 |
Lathrop (8) (n = 3) | 27–62 | Cervix (1), “uterus” (1), corpus + cervix (1) | AUB | IV (3) | DLCL (2), small cleaved (1) | ND (3) | RT (3), CT (1), surgery (1) | 0 |
Makarewicz and Kuzminska (10) (n = 3) | 33–65 | Cervix (3) | AUB | IE (2) N/A (1) | DLCL (1), FCL-D (1), LBL (1) | B-cell (3) | CT (3), RT (2), surgery (1) | N/A |
Maryniak and Nasierowska-Guttmejer (11) (n = 3) | 24–72 | Cervix (3) | AUB | IE (1) IIE (2) | DLCL (2), DSCCL (1) | B-cell (3) | RT (3), surgery (2), CT (1) | 0 |
van de Rijn et al. (16) (n = 3) | 64–68 | Corpus (3) | Variable | “Low stage” (3) | “low-grade” (3) | B-cell (3) | Surgery (3) | N/A |
Osborne et al. (14) (n = 3) | 11–70 | “Uterus” (3) | All patients had ovarian lymphoma | IV (3) | DLCL (2), DSNC (1) | ND | Surgery (3), CT (1) | 33 |
